ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 453

Including Pain, Fatigue and Functionality Regularly in the Assessment of Patients with Early Rheumatoid Arthritis Separately Adds to the Evaluation of Disease Status

Sofia Pazmino1, Anikó Lovik 2, Annelies Boonen 3, Diederik De Cock 1, Veerle Stouten 1, Johan Joly 4, Kristien Van der Elst 5, Delphine Bertrand 1, Rene Westhovens 6 and Patrick Verschueren 5, 1KU Leuven, Leuven, Belgium, 2Leuven Biostatistics and Statistical Bioinformatics Center, KU Leuven, Leuven, Vlaams-Brabant, Belgium, 3Maastricht University Medical Center, Maastricht, Netherlands, 4University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium, 5University Hospital Leuven, Leuven, Belgium, 6University Hospitals, Leuven, Belgium

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Disease Activity, pain and fatigue, patient-reported outcome measures, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) level of disease activity, cannot be evaluated by a single clinical or laboratory measurement. Hence, composite indices have been created via factor analysis (FA). FA uncovers the fact that multiple observed variables have similar patterns of responses because they are all associated with a latent, not directly observable, variable. Yet, only one directly patient-reported outcome (PRO), the patient’s global (PaGH), has been included in the composite indices. The PaGH answers a very general question of “Considering all the ways your RA has affected you how would you say your health is?”, making it easy to apply but hard to interpret. Lately, more specific PROs have been proven to add valuable and unique information on the patient’s disease state. We wanted to see if this is the case in early RA.

Methods: In the Care in early rheumatoid arthritis (CareRA) trial, patients with early RA (≤1 year) (n=379) naïve to DMARDs were randomized to one of four remission induction treatment schemes and followed up over 2 years (Verschueren et al, 2015). Key clinical variables such as swollen (SJC) and tender joint count (TJC), patient (PaGH) and physician (PrGH) global health assessment, CRP or ESR; along with pain, fatigue and physical function (Health Assessment Questionnaire-HAQ) were recorded at every consultation. Exploratory factor analysis (EFA) was performed for all observations and per time point as well on (1) key set variables only and (2) when also including other PROs. Pearson correlations of all variables were calculated. Firstly, missing data was handled using multiple imputation resulting in 15 complete datasets. Next, clustering was removed by performing multiple outputation 1000 times on the 15 datasets. Each of the 15 000 datasets was analyzed by EFA with oblimin rotation. The analyses were combined after re-ordering the factors by maximizing factor congruence.

Results: The different factor analyses (FAs) based on the classical components of disease activity scores, supported the traditional approach of composite indices extracting 2 factors that are stable over time, meaning no substantial cross-loadings between factors (Table 1). Still, pain (0.83), fatigue (0.65) and HAQ (0.59) were strongly correlated with PaGH in our cohort (Table 2). When rerunning the FA including also these variables, the 2-factor model was no longer stable with variables changing the factors in which they loaded over time. However, when a 3-factor model was extracted, there were large positive loadings on Factor 1 describing the patient’s personal assessment, Factor 2 clinical assessment and Factor 3 laboratory (Table 3).

Conclusion: The classical FA with the key variables gives a 2-factor model that bundles everything in one, except for acute phase reactants (CRP and ESR). However, PaGH seems to be associated with pain, fatigue, and functionality. By including these variables, a third factor dedicated to the patient’s perceptions is extracted and a very clear factor structure showing three latent factors is present. This could indicate that these patient’s assessments should be added to the standard measurements of disease state.


Table 1

Table 1


Table 2

Table 2


Table 3

Table 3


Disclosure: S. Pazmino, None; A. Lovik, None; A. Boonen, AbbVie, 2, Amgen, 2, Celgene, 2, Eli Lilly and Company, 5, Janssen, 8, Lilly, 5, 8, Novartis, 5, Sandoz, 5, 8, UCB, 5, 8; D. De Cock, None; V. Stouten, None; J. Joly, None; K. Van der Elst, None; D. Bertrand, None; R. Westhovens, Celltrion, 5, 8, 9, Celltrion, Inc., 2, 5, Galapagos, 5, 8, Galapagos NV, 5, 9, Galapagos/Gilead, 2, 5, Gilead Sciences, Inc., 5, 8, 9; P. Verschueren, None.

To cite this abstract in AMA style:

Pazmino S, Lovik A, Boonen A, De Cock D, Stouten V, Joly J, Van der Elst K, Bertrand D, Westhovens R, Verschueren P. Including Pain, Fatigue and Functionality Regularly in the Assessment of Patients with Early Rheumatoid Arthritis Separately Adds to the Evaluation of Disease Status [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/including-pain-fatigue-and-functionality-regularly-in-the-assessment-of-patients-with-early-rheumatoid-arthritis-separately-adds-to-the-evaluation-of-disease-status/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/including-pain-fatigue-and-functionality-regularly-in-the-assessment-of-patients-with-early-rheumatoid-arthritis-separately-adds-to-the-evaluation-of-disease-status/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology